Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Quipt Home Medical Enters Cooperation Agreement With Kanen; Grants Kanen Certain Board Access Rights

Author: Benzinga Newsdesk | March 04, 2025 07:41am

Kanen has agreed to withdraw its notice of its intent to solicit proxies in support of four director candidates at the Company's upcoming 2025 annual general meeting of shareholders in opposition to the director candidates recommended by the Company.

As part of the Agreement, the Company's Board of Directors has granted Kanen certain Board access rights for as long as Kanen maintains aggregate beneficial ownership of at least 3.5% of the Company's outstanding shares. 

Posted In: QIPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist